{"transactions":[{"id":1556407,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-28","kind":"sale","planned":true,"acquired":false,"shares":693076,"price":0.1459,"value":101119.7884,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":1080000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556406,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-27","kind":"sale","planned":true,"acquired":false,"shares":306924,"price":0.1699,"value":52146.3876,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":1773076,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556405,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-26","kind":"sale","planned":true,"acquired":false,"shares":2000000,"price":0.1965,"value":393000.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":2080000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556404,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":780000,"price":0.2189,"value":170742.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":4080000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556403,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-22","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":0.23,"value":4600.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":4860000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556402,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-01-11","kind":"sale","planned":true,"acquired":false,"shares":400000,"price":0.2256,"value":90240.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":4880000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}}]}